Search results
Found 28 matches for
Blood cancer patients should continue treatment at time of COVID-19 vaccination, OCTRU study shows
9 April 2025
Evidence shows for patients with a type of leukaemia, pausing BTKi therapy for COVID-19 vaccination does not improve antibody responses to the vaccine
Global study supports the immunity debt hypothesis for flu after Covid restrictions
7 April 2025
A new NDORMS study supports the hypothesis of immunity debt showing increases of influenza rates one year after global relaxation of COVID-19 restrictions. It highlights the need for proactive preparations in future pandemic response strategies.
NDORMS study highlights lingering symptoms long after COVID-19 infection
15 November 2024
A new international study has shed light on the significant burden of post-acute COVID-19 symptoms across N. America, Europe and Asia.
Post-acute infection syndrome is not unique to COVID-19
25 October 2024
Patients hospitalised with COVID-19 often report a wide range of symptoms months after their initial illness. But a new study from NDORMS shows that post-acute infection syndrome (PAIS) is not unique to COVID-19 and can also occur after other respiratory infections.
Healthy lifestyle lowers the risk of post-COVID complications
13 August 2024
A new NDORMS study has found that a healthy lifestyle can significantly reduce the risk of post-COVID complications, hospitalisation, and death.
Cracking the genetic code for COVID-19 vaccine effectiveness
21 May 2024
Researchers have unveiled critical insights into how our genetic makeup influences the body's response to COVID-19 vaccines. The study, published in Nature Communications, may open new paths to personalised vaccination strategies.
COVID-19 vaccines effectiveness: results from Norway demonstrate the reproducibility of federated analytics
11 April 2024
Researchers from NDORMS and the University of Oslo, have successfully replicated findings from recently published international studies on the effectiveness of COVID-19 vaccines to prevent long COVID and post-acute complications.
New study reveals long-term mental health risks after COVID-19
21 March 2024
A new study published in Nature Human Behaviour sheds light on the long-term mental health consequences of COVID-19 infection and the growing evidence of the protective effect of vaccination on reducing the risk.
COVID-19 vaccines found effective in reducing long COVID symptoms
12 January 2024
A recent study has revealed the effectiveness of COVID-19 vaccines in preventing long COVID.
Patients can interrupt treatment of immune-supressing medicines for two-weeks in order to boost immunity provided by COVID-19 booster vaccine, finds major study
14 December 2023
A major clinical trial, led by the University of Nottigham and managed by the Oxford Clinical trials Research Unit (OCTRU), has shown that people with inflammatory conditions are able to improve the antibody response from a COVID-19 booster vaccination by interrupting their treatment for two weeks immediately after having the vaccine.
Study reveals new evidence on rare blood-clotting condition after covid-19 vaccination
28 October 2022
Researchers from NDORMS at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.
Daniel Prieto-Alhambra receives ISPE award for COVID-19 research
1 September 2022
Daniel Prieto-Alhambra has been awarded the 'Special ISPE award for contributions to public health associated with the COVID-19 pandemic.'
Junqing Xie awarded by the International Society for Pharmacoepidemiology
30 August 2022
Congratulations to Junqing (Frank) Xie who has been awarded the Stanley A. Edlavitch Award from The International Society for Pharmacoepidemiology (ISPE).
Higher risk of blood clots in COVID-19 outpatients, largely reduced after vaccination
19 August 2022
Researchers at NDORMS have studied the association between ambulatory COVID-19 and short-term risk of venal thrombosis and the clinical and genetic risk factors predisposing them to developing post–COVID-19 thrombosis.
OCTRU collaboration boosts understanding of COVID vaccine response
21 July 2022
Working with researchers across multiple universities, the Oxford Clinical Trials Unit (OCTRU) played a key role in delivering results of the national VROOM trial (Vaccine Response On Off Methotrexate).
Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination
29 June 2022
The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.
COVID-19’s high blood clot risk
14 May 2022
A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
23 March 2022
The COVID-19 Multi-omic Blood Atlas (COMBAT) has identified blood hallmarks of COVID-19 involving particular immune cell populations and their development, components of innate and adaptive immunity, and connectivity with the inflammatory response.
No link found between COVID-19 vaccines and neurological events
16 March 2022
But researchers find an increased risk for unvaccinated people infected with SARS-CoV-2.
Oxford leads global cross-collaboration Covid research
14 March 2022
A new collaboration between Oxford, Brazil and Pakistan has been funded by the Bill & Melinda Gates Foundation. The partnership will provide researchers with de-identified health data from two of the worlds global COVID-19 hotspots to increase understanding of COVID-19 in these communities and help accelerate the management of the disease.